Grössmann, N. and Rothschedl, E. and Wolf, S. (2019): Horizon Scanning in Oncology 40th Prioritisation – 3rd quarter 2019. HSO: 40th Prioritisation.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
For the 40th prioritisation (July 2019), eleven drugs were filtered out of 570 identified and were sent to prioritisation. Of these, 6 drugs were ranked as 'highly relevant' by the expert panel, 5 as 'relevant' and none as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
|Item Type:||DSD: Horizon Scanning in Oncology|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
QZ Pathology > QZ 200-380 Neoplasms.Cysts
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
|Series Name:||HSO: 40th Prioritisation|
|Deposited on:||29 Jul 2019 15:24|
|Last Modified:||29 Jul 2019 15:24|
Repository Staff Only: item control page